Sign In
Buy RAIN
$2.21
-0.115 (-4.96%)
At Close: Jun 03, 2026
NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Rain Oncolog
Shareholder Alert: Ademi LLP investigates whether Rain Oncology Inc. has obtained a Fair Price in its transaction with Pathos
10:41am, Thursday, 14'th Dec 2023
MILWAUKEE , Dec. 14, 2023 /PRNewswire/ -- Ademi LLP is investigating Rain (NASDAQ: RAIN) for possible breaches of fiduciary duty and other violations of law in its transaction with Pathos. Click here
RAIN Stock Alert: Halper Sadeh LLC Is Investigating Whether the Sale of Rain Oncology Inc. Is Fair to Shareholders
02:42am, Thursday, 14'th Dec 2023
NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Rain Oncology Inc. (NASDAQ: RAIN) to Pathos AI, Inc. for $1.16 in cash per share plus a n
Rain Oncology Enters into Agreement to be Acquired by Pathos AI for $1.16 in Cash per Share Plus Contingent Value Rights
06:05pm, Wednesday, 13'th Dec 2023
NEWARK, Calif., Dec. 13, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (Nasdaq: RAIN) (“Rain”), today announced it has entered into a definitive merger agreement whereby Pathos AI, Inc. (“Pathos�
Rain Oncology Reports Third Quarter 2023 Financial Results and Provides Business Update
04:01pm, Thursday, 09'th Nov 2023
NEWARK, Calif., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Rain Oncology Inc. (NasdaqGS: RAIN) (Rain) today reported financial results for the third quarter ended September 30, 2023, along with an update on th
3 Top Penny Stocks to Buy According To Insiders In October
10:35am, Monday, 16'th Oct 2023
Penny stocks, defined as stocks trading under $5 per share, offer traders huge upside potential but also carry significant risks. One strategy used by some investors to identify promising penny stocks
Rain Oncology Confirms Receipt of Unsolicited Proposal from Concentra Biosciences
08:00am, Monday, 16'th Oct 2023
NEWARK, Calif., Oct. 16, 2023 (GLOBE NEWSWIRE) -- Rain Oncology, Inc. (NasdaqGS: RAIN) (“Rain”) confirmed that it has received an unsolicited proposal from Tang Capital, LP on behalf of Concentra
NEW YORK , Sept. 11, 2023 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Rain Oncology Inc. (NASDAQ: RAIN) between July 20, 2021 and May 1
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz reminds investors of the upcoming September 12, 2023 deadline to file a lead plaintiff motion in the class action filed on behalf of inve
NEW YORK, NY / ACCESSWIRE / September 11, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la
SHAREHOLDER ALERT: The Law Offices of Vincent Wong Remind Rain Investors of a Lead Plaintiff Deadline of September 12, 2023
05:45am, Monday, 11'th Sep 2023
NEW YORK , Sept. 11, 2023 /PRNewswire/ -- Attention Rain Oncology Inc. ("Rain") (NASDAQ: RAIN) shareholders: The Law Offices of Vincent Wong announce that a class action lawsuit has commenced on behal
NEW YORK, NY / ACCESSWIRE / September 10, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la
NEW YORK, NY / ACCESSWIRE / September 10, 2023 / If you suffered a loss on your Rain Oncology Inc. (NASDAQ:RAIN) investment and want to learn about a potential recovery under the federal securities la
